Page last updated: 2024-12-08
4-aminocyclohexanecarboxylic acid
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
4-aminocyclohexanecarboxylic acid: RN for cpd without isomeric designation not in Chemline 12/6/82 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 171560 |
| SCHEMBL ID | 218064 |
| SCHEMBL ID | 13370015 |
| SCHEMBL ID | 384165 |
| SCHEMBL ID | 382975 |
| SCHEMBL ID | 10343476 |
| MeSH ID | M0055410 |
Synonyms (108)
| Synonym |
|---|
| 4-amino-cyclohexane-1-carboxylic acid |
| nsc12784 |
| nsc-12784 |
| nsc-12785 |
| 3685-23-2 |
| 3685-25-4 |
| nsc12785 |
| 4-aminocyclohexanecarboxylic acid |
| trans-4-aminocyclohexanecarboxylic acid |
| OPREA1_021616 |
| cis-4-aminocyclohexanecarboxylic acid, 95% |
| cis-4-aminohexahydrobenzoic acid |
| 1776-53-0 |
| A1278 |
| 4-aminohexahydrobenzoic acid |
| cis-4-aminocyclohexanecarboxylic acid |
| FT-0660540 |
| A812284 |
| AKOS004120822 |
| cis-4-aminohexahydrobenzoic acid; (cis)-4-aminocyclohexanecarboxylic acid; cis-4-amino-1-cyclohexanecarboxylic acid; |
| A6342 |
| AKOS005259585 |
| 4-aminocyclohexane-1-carboxylic acid |
| STK724071 |
| EN300-48596 |
| 4-amino-1-carboxycyclohexane |
| 4-amino cyclohexane-l-carboxylic acid |
| (1r,4r)-4-aminocyclohexanecarboxylic acid;trans-4-amino-cyclohexanecarboxylic acid |
| AKOS006341988 |
| trans-4-aminocyclohexane carboxylic acid |
| trans-4-amino-cyclohexanecarboxylic acid |
| BP-12344 |
| cis-4-amino-1-cyclohexanecarboxylic acid |
| FT-0633834 |
| FT-0623917 |
| FT-0649394 |
| cis-4-aminocyclohexane carboxylic acid |
| PB21681 |
| AM20112001 |
| (1r,4r)-4-aminocyclohexane-1-carboxylic acid |
| SCHEMBL218064 |
| DRNGLYHKYPNTEA-OLQVQODUSA-N |
| cis-4-amino cyclohexyl carboxylic acid |
| cis-4-amino-1-cyclohexane carboxylic acid |
| cis-4-aminocyclohexane-1-carboxylic acid |
| cis-4-aminocyclohexyl carboxylic acid |
| cis-4-aminocyclohexane-carboxylic acid |
| cis-4-amino-cyclohexanecarboxylic acid |
| cis-4-aminocyclohexylcarboxylic acid |
| cis-aminocyclohexane-4-carboxylic acid |
| PB10129 |
| (trans)-4-aminocyclohexanecarboxylic acid |
| DRNGLYHKYPNTEA-IZLXSQMJSA-N |
| trans-4-aminocyclohexylcarboxylic acid |
| trans 4-amino-cyclohexanecarboxylic acid |
| SCHEMBL13370015 |
| 4-aminocyclohexane carboxylic acid |
| 4-amino-cyclohexanecarboxylic acid |
| 4-amino-1-cyclohexanecarboxylic acid |
| DRNGLYHKYPNTEA-UHFFFAOYSA-N |
| 4-aminocyclohexylcarboxylic acid |
| (1r,4r)-4-aminocyclohexanecarboxylic acid |
| 4-aminocyclohexane-carboxylic acid |
| (1s,4s)-4-aminocyclohexanecarboxylic acid |
| 4-amino cyclohexanecarboxylic acid |
| SCHEMBL384165 |
| SCHEMBL382975 |
| cyclohexanecarboxylic acid, 4-amino- |
| cyclohexanecarboxylic acid, 4-amino-, cis- |
| cyclohexanecarboxylic acid, 4-amino-, trans- |
| SCHEMBL10343476 |
| 3085-23-2 |
| STR06482 |
| (1s,4s)-4-aminocyclohexane-1-carboxylic acid |
| uk 22314 |
| (cis-4-carboxycyclohexyl)amine |
| 1,4-cis-aminocyclohexanecarboxylic acid |
| (+-)-cis-4-aminocyclohexanecarboxylic acid |
| nsc 12784 |
| mfcd00191730 |
| mfcd00209953 |
| J-525018 |
| J-520086 |
| CS-W008392 |
| 4-aminocyclohexanecarboxylic acid, aldrichcpr |
| nsc 12785 |
| CS-W005514 |
| mfcd00191601 |
| trans-4-aminocyclohexanecarboxylic acid, aldrichcpr |
| J-011305 |
| SY029216 |
| 4-azanylcyclohexane-1-carboxylic acid |
| BCP17255 |
| BCP19613 |
| DS-11045 |
| DS-13960 |
| BCP26653 |
| AM9683 |
| AM9731 |
| SY002609 |
| Q27456527 |
| DTXSID30901273 |
| noname_367 |
| SY038982 |
| CS-W016414 |
| EN300-135332 |
| p-amino cyclohexylcarboxylic acid |
| EN300-86278 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (7)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 3 (42.86) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 12.51
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.51) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 7 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||